000			01921 a2200481 4500
005			20250516053147.0
264		0	_c20111108
008			201111s 0 0 eng d
022			_a1524-4563
024	7		_a10.1161/HYPERTENSIONAHA.111.175349 _2doi
040			_aNLM _beng _cNLM
100	1		_aLloyd, Eric E
245	0	0	_aDisruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice. _h[electronic resource]
260			_bHypertension (Dallas, Tex. : 1979) _cOct 2011
300			_a672-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology
650	0	4	_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAorta _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCalcium Channel Agonists _xpharmacology
650	0	4	_aDisease Models, Animal
650	0	4	_aHypertension _xetiology
650	0	4	_aMembrane Potentials _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aPotassium Channels, Tandem Pore Domain _xdeficiency
650	0	4	_aPotassium Chloride _xpharmacology
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasoconstrictor Agents _xpharmacology
650	0	4	_arho-Associated Kinases _xphysiology
700	1		_aCrossland, Randy F
700	1		_aPhillips, Sharon C
700	1		_aMarrelli, Sean P
700	1		_aReddy, Anilkumar K
700	1		_aTaffet, George E
700	1		_aHartley, Craig J
700	1		_aBryan, Robert M
773	0		_tHypertension (Dallas, Tex. : 1979) _gvol. 58 _gno. 4 _gp. 672-8
856	4	0	_uhttps://doi.org/10.1161/HYPERTENSIONAHA.111.175349 _zAvailable from publisher's website
999			_c21118456 _d21118456